Stockscreener 앱 받기
0.949
5.46%
0.0491
시간 외 거래:
.90
-0.049
-5.16%
Revelation Biosciences Inc 주식(REVB)의 최신 뉴스
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Greenville Online
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - The Des Moines Register
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Marco Eagle
Revelation Biosciences (REVB) to Present Kidney Disease Treatment Data at Conference - Intellectia AI
Revelation Bio To Share New Data From PRIME Study Of Gemini In March - Nasdaq
EPS Watch: Will ZBAI stock recover after earningsGlobal Markets & Weekly High Return Opportunities - baoquankhu1.vn
Breakout Zone: Can Revelation Biosciences Inc lead its sector in growth2025 Market Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn
Whittier Daily News - FinancialContent
Aug Opening: What risks investors should watch in Revelation Biosciences Inc Equity Warrant stock - Bộ Nội Vụ
Wall Street Recap: Can Revelation Biosciences Inc beat the S P 500Weekly Trade Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Earnings Recap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesEarnings Summary Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Why Revelation Biosciences Inc. stock remains resilient2025 Valuation Update & Verified Technical Trade Signals - Улправда
Bond Watch: Why Revelation Biosciences Inc stock is a must watch in 2025Watch List & Technical Entry and Exit Tips - Bộ Nội Vụ
HOKA Recommended Models: Is Revelation Biosciences Inc. Equity Warrant stock a buy for dividend growthDaily Trainer Picks & trail grip notes for mixed terrain - Улправда
How to contact the Daily Bulletin - FinancialContent
How Revelation Biosciences Inc. stock performs after earningsDollar Strength & Entry Point Confirmation Signals - ulpravda.ru
Is Revelation Biosciences Inc. Equity Warrant stock attractive after correctionPortfolio Performance Report & AI Powered Market Entry Strategies - ulpravda.ru
Will Revelation Biosciences Inc. stock benefit from AI adoptionMarket Sentiment Report & Fast Entry Momentum Trade Alerts - ulpravda.ru
Is Revelation Biosciences Inc. Equity Warrant stock ready for breakoutJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - Улправда
Why Revelation Biosciences Inc. stock is a must watch in 2025Trade Risk Assessment & Daily Stock Momentum Reports - Улправда
Why Revelation Biosciences Inc. stock attracts high net worth investorsMarket Risk Report & Momentum Based Trading Signals - Улправда
Is Revelation Biosciences Inc. Equity Warrant stock affected by interest rate hikes2025 Key Highlights & Daily Oversold Stock Bounce Ideas - Улправда
Can Revelation Biosciences Inc. stock deliver sustainable ROESell Signal & Entry Point Confirmation Alerts - ulpravda.ru
How Revelation Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - Улправда
How Revelation Biosciences Inc. stock trades during market volatilityWeekly Trend Report & AI Based Buy/Sell Signal Reports - ulpravda.ru
Will Revelation Biosciences Inc. Equity Warrant stock reach all time highs in 2025 - Улправда
Revelation Biosciences, Inc.Common Stock (NQ: REVB - FinancialContent
Revelation Biosciences begins GMP manufacturing for GEMINI trials By Investing.com - Investing.com Nigeria
Revelation Biosciences begins GMP manufacturing for GEMINI trials - Investing.com
MarketsFinancial Advisors - FinancialContent
Upcoming EventsRevelation Biosciences, Inc.Warrant (Nasdaq:REVBW) Stock Quote - FinancialContent
Potential acute kidney injury drug moves toward larger clinical trials - Stock Titan
4.73%
0.92%
자본화:
|
볼륨(24시간):